BACTROBAN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug BACTROBAN contains one active pharmaceutical ingredient (API):

1 Mupirocin UNII RG38I2P540 - MUPIROCIN CALCIUM

Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally. Read about Mupirocin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BACTROBAN 2% Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
BACTROBAN Nasal ointment	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06AX09	Mupirocin	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX09
R01AX06	Mupirocin	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AX Other nasal preparations
Discover more medicines within R01AX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4348W, 4350Y, 9440W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510601301160316, 510614020051403
Country: EE	Ravimiamet	Identifier(s): 1110283, 1272743, 1865224
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58868, 59531
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 545681, 568709
Country: FR	Base de données publique des médicaments	Identifier(s): 66325311
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138358, 142019, 142021, 161401, 165417, 165419, 29069, 29081, 29085
Country: HK	Department of Health Drug Office	Identifier(s): 28186, 33588
Country: IE	Health Products Regulatory Authority	Identifier(s): 13716, 13765, 13773, 36830
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 976, 977
Country: JP	医薬品医療機器総合機構	Identifier(s): 6119700M1035
Country: MT	Medicines Authority	Identifier(s): MA192/02401, MA192/02402, MA192/02403, PI908/10601A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 037M86
Country: NL	Z-Index G-Standaard	Identifier(s): 13250728, 13577395
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 21156, 32085
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4227
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100008702, 100008719, 100098125, 100162952, 100241723, 100241746, 100272221, 100298717, 100298976, 100304398, 100324484, 100366146, 100384865, 100384888, 100394177, 100396816, 100399051, 100405053, 100421595, 100425185, 100427563, 100431820, 100437202, 100443740, 100459033, 100460327
Country: SG	Health Sciences Authority	Identifier(s): 00554P, 05075P, 11204P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5143011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522355426, 8699522358014, 8699522385522, 8699522385539
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/20.1.6/0274, T/20.1.6/0075, W/20.1.6/218